Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 119.80 | -167.52 | 441.03 | 349.11 |
Depreciation/ Depletion | 740.56 | 676.69 | 586.18 | 60.96 |
Non- Cash Items | 535.32 | 458.84 | 200.92 | -52.00 |
Changesin Working Capital | -391.14 | -484.12 | -384.97 | -323.35 |
Cashfrom Operating Activities | 1,004.54 | 483.89 | 843.16 | 34.72 |
Capital Expenditures | -712.04 | -964.75 | -889.51 | -58.11 |
Other Investing Cash Flow Items Total | 278.03 | -374.03 | -922.59 | -4,324.78 |
Cashfrom Investing Activities | -434.01 | -1,338.78 | -1,812.10 | -4,382.89 |
Financing Cash Flow Items | -483.74 | -278.12 | -144.51 | 881.56 |
Total Cash Dividends Paid | 0.00 | -67.00 | -50.00 | - |
Issuance( Retirement)of Stock Net | 1,050.00 | - | - | 3,523.41 |
Issuance( Retirement)of Debt Net | -988.62 | 1,162.91 | 988.70 | 89.19 |
Cashfrom Financing Activities | -422.36 | 817.79 | 794.19 | 4,494.16 |
Foreign Exchange Effects | 17.79 | 5.15 | -2.04 | - |
Net Changein Cash | 165.96 | -31.95 | -176.79 | 145.99 |
Cash Interest Paid | 469.61 | 278.12 | 144.51 | 4.29 |
Cash Taxes Paid | 156.84 | 189.00 | 169.42 | 95.29 |
Piramal Pharma Dividend Piramal Pharma Bonus Piramal Pharma News Piramal Pharma AGM Piramal Pharma Rights Piramal Pharma Splits Piramal Pharma Board Meetings Piramal Pharma Key Metrics Piramal Pharma Shareholdings Piramal Pharma Profit Loss Piramal Pharma Balance Sheet Piramal Pharma Q1 Results Piramal Pharma Q2 Results Piramal Pharma Q3 Results Piramal Pharma Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks